Cwm, LLC Autolus Therapeutics PLC Transaction History

Cwm, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 28, 2020	SELL	$4.2 - $13.0 $147 - $455	-35 Reduced 77.78%	10 $0
Q4 2019 Jan 27, 2020	SELL	$11.13 - $16.28 $211 - $309	-19 Reduced 29.69%	45 $1,000
Q3 2019 Oct 22, 2019	SELL	$9.79 - $16.72 $443,682 - $757,750	-45,320 Reduced 99.86%	64 $1,000
Q2 2019 Jul 31, 2019	BUY	$15.1 - $31.25 $155,137 - $321,062	10,274 Added 29.26%	45,384 $731,000
Q1 2019 Apr 22, 2019	BUY	$24.38 - $34.71 $855,981 - $1.22 Million	35,110 New	35,110 $1.11 Million

114

160M

2.8K

89.9K

Ticker AUTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,909,800
Market Cap $185M
Description
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

Stay updated on Cwm, LLC with notifications on news.